siRNA therapy decreases triglycerides in individuals with rare health condition

.ANALYSIS HIGHLIGHT.19 September 2024. Plozasiran lowered triglyceride levels by 80% and also decreased the threat of pancreatitis in individuals along with chronic chylomicronemia, with or even without a hereditary diagnosis.